In conclusion, we investigated the circulating levels of mir-29a-3p/mir-92a-3p in AML patients and we found that both species were downregulated in the patients’ plasma and they are negatively correlated with their target gene MCL1 transcript levels. Here, MCL1 is linked to acute myeloid leukemia.